Neonatal nitric oxide use: Predictors of response and financial implications

Journal of Perinatology

Volumn 23, Issue 2, 2003, Pages 128-132

  Truog, William E ^a   Castor, Cheri A ^a   Sheffield, Mark J ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; OXYGEN;

ARTICLE; ARTIFICIAL VENTILATION; CALCULATION; COMMERCIAL PHENOMENA; CONTROLLED STUDY; COST CONTROL; EXTRACORPOREAL OXYGENATION; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN MORTALITY; OXYGEN THERAPY; TREATMENT OUTCOME;

COSTS AND COST ANALYSIS; EXTRACORPOREAL MEMBRANE OXYGENATION; HUMANS; INFANT, NEWBORN; MISSOURI; NITRIC OXIDE; RESPIRATION, ARTIFICIAL; TREATMENT OUTCOME;

EID: 0037366705     PISSN: 07438346     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jp.7210864     Document Type: Article

References (20)

1. Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl J Med 1997;336(9):597-604.
2. Roberts JD, Fineman JR, Mortin III FC, et al. For the Inhaled Nitric Oxide Study Group. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. N Engl J Med 1997;336(9):605-10.
3. Davidson D, Barefield ES, Kattwinkel J, et al. Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double-masked, placebo-controlled, dose-response, multicenter study. Pediatrics 1998;101(3):325-34.
4. Clark RH, Kueser TJ, Walker MW, et al. For the Clinical Inhaled Nitric Oxide Research Group. Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. N Engl J Med 2000;342(7):469-74.
5. Day RW, Lynch JM, White KS, Ward RM. Acute response to inhaled nitric oxide in newborns with respiratory failure and pulmonary hypertension. Pediatrics 1996;98(4):698-705.
6. Truog WE. Inhaled nitric oxide. A tenth anniversary observation. Pediatrics 1998;101:696-97.
7. Goldman AP, Tasker RC, Haworth SG, Sigston PE, Macrae DJ. Four patterns of response to inhaled nitric oxide for persistent pulmonary hypertension of the newborn. Pediatrics 1996;98(4):706-13.
8. George TN, Johnson KJ, Bates JN, Segar JL. The effect of inhaled nitric oxide therapy on bleeding time ands platelet aggregation in neonates. J Pediatr 1998;132:731-4.
9. Kobayashi T, Gabazza EC, Shimizu S, et al. Long-term inhalation of high-dose nitric oxide increases intraalveolar activation of coagulation system in mice. Am J Respir Crit CAre Med 201;1676-82.
10. Hallman M, Bry K, Turbow R, Waffarn F, Lappalainen U. Pulmonary toxicity associated with nitric oxide in term infants with severe respiratory failure. J Pediatr 1998;132(5):827-9.
11. Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric oxide and hypoxic respiratory failure in infants with congenital diaphragmatic hernia. Pediatrics 1997;99(6):838-45.
12. Kinsella JP, Truog WE, Walsh WF, et al. Randomized multicenter trial of inhaled nitric oxide and high frequency oscillatory ventillation in severe persistent pulmonary hypertension of the newborn. J Pediatr 1997;131:55-62.
13. Zhou H, Gao Y, Raj JU. Antenatal betamethasone therapy augments nitric oxide-mediated relaxation of preterm ovine pulmonary veins. Am Physiol Soc 1996;390-96.
14. Pearson DL, Dawling S, Walsh WF, et al. Neonatal pulmonary hypertension. Ures-cycle intermediates, nitric oxide production, and carbonyl-phosphate synthetase function. N Engl J Med 2001;344(24):1832-38.
15. Christenson J, Lavoie A, O'Connor M, Bhorade S, Pohlman A, Hall JB. The incidence and pathogenesis of cardiopulmonary deterioration after abrupt withdrawal of inhaled nitric oxide. Am J Respir Cret Care Med 2000;161: 1443-9.
16. Kinsella JP, Abman SH. Clinical approach to inhaled nitric oxide therapy in the newborn with Hypoxemia. J Pediatr 2000;136(6)717-26.
17. Walsh-Sukys MC, Tyson JE, Wright LL, et al. Persistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcomes. Pediatrics 2000;105(1):14-20.
18. Kinsella JP, Torielli F, Ziegler JW, Ivy DD, Abman SH. Dipyridamole augmentation of response to NO. Lancet 1995;346:647-8.
19. Thusu KG, Morin FC, Russell JA, Steinhorn RH. The cGMP phosphodiesterase inhibitor zaprinast enhances the effect of NO. Am J Respir Cit Care Med 1995;152:1605-10.
20. Truog WE, Norberg M, Thibeault DW. Effect of inhaled nitric oxide in endothelin-1-induced pulmonary hypertension. Biol Neonate 1998;73: 246-53.